FDA Inspection 1089874 — Hetero Labs Ltd. - Unit IX
The FDA completed an inspection of Hetero Labs Ltd. - Unit IX on May 14, 2019 in Visakhapatnam. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 14, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Visakhapatnam (India)